📰 Mckesson News
Page 55 - Mckesson News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mckesson. Real-time updates on events, politics, business and more.
January 2, 2024
Coherus BioSciences, Inc. (CHRS) announced that LOQTORZI is now available through select specialty distributors in the United States. LOQTORZI is indicated in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma, and as monotherapy for the treatment of adults with recurrent, unresectable, or metastatic NPC with disease progression on or after platinum-containing chemotherapy.
January 2, 2024
CHARLESTON — A feud between West Virginia’s top attorney and an anti-lawsuit abuse group continues to play out following the awarding of millions of dollars
January 2, 2024
– Launch of LOQTORZI offers first and only FDA-approved treatment for NPC in all lines of therapy – – Indicated in combination with chemotherapy for 1st line treatment and as monotherapy for...
January 1, 2024
CHARLESTON – A feud between West Virginia’s top attorney and an anti-lawsuit abuse group continues to play out following the awarding of millions of dollars in outside attorney fees for major cases. In a report set to be released in the coming days, West Virginia Citizens Against Lawsuit Abuse alleges that state Attorney General Patrick […]
January 1, 2024
Advisory Services Network LLC boosted its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 0.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,295 shares of the company’s stock after buying an additional 137 shares during the quarter. Advisory Services Network […]
January 1, 2024
Skopos Labs Inc. purchased a new position in McKesson Co. (NYSE:MCK – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 886 shares of the company’s stock, valued at approximately $410,000. Other large investors have also bought and sold shares of the company. […]
January 1, 2024
The Supreme Court on Monday declined to hear an appeal from Black Lives Matters organizer DeRay Mckesson, letting stand a lower court’s decision that some critics fear could wind up
January 1, 2024
McKesson Co. (NYSE:MCK – Free Report) – Equities researchers at Zacks Research increased their Q1 2025 EPS estimates for McKesson in a research report issued on Tuesday, May 28th. Zacks Research analyst I. Bandyopadhyay now forecasts that the company will earn $7.16 per share for the quarter, up from their previous forecast of $6.96. The […]
January 1, 2024
McKesson Co. (NYSE:MCK – Get Free Report) CFO Britt J. Vitalone sold 894 shares of the company’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $557.40, for a total transaction of $498,315.60. Following the completion of the sale, the chief financial officer now directly owns 16,455 […]
December 30, 2023
CHARLESTON — A feud between West Virginia’s top attorney and an anti-lawsuit abuse group continues to play out following the awarding of millions of dolla